Review: the history and role of naturally occurring mouse models with Pde6b mutations

Juanjuan Han1, Astra Dinculescu2, Xufeng Dai1

  • 1Eye Hospital, School of Ophthalmology & Optometry, Wenzhou Medical University, Wenzhou, Zhejiang, China.

Molecular Vision
|December 25, 2013
PubMed

Insights

Mouse models with Pde6b gene mutations offer insights into autosomal recessive retinitis pigmentosa (arRP). Gene therapy and other strategies show promise for restoring vision and slowing retinal degeneration in these models.

Area of Science:

  • Genetics
  • Ophthalmology
  • Neuroscience

Background:

  • Inherited retinal diseases like retinitis pigmentosa (RP) impact millions globally.
  • Mutations in the PDE6B gene are a frequent cause of autosomal recessive RP (arRP).
  • Naturally occurring mouse models with Pde6b mutations mimic human arRP phenotypes, aiding research.

Purpose of the Study:

  • To review established mouse models of arRP caused by Pde6b mutations.
  • To discuss the discovery, characteristics, and degeneration mechanisms of these models.
  • To explore therapeutic strategies for vision restoration and disease progression delay.

Main Methods:

  • Focus on two well-characterized spontaneous Pde6b mutant mouse models.
  • Analysis of genetic mutations, phenotypic expression, and disease mechanisms.
  • Review of current and emerging therapeutic approaches.

Main Results:

  • These mouse models accurately reflect human arRP genetic and phenotypic features.
  • Detailed understanding of photoreceptor degeneration pathways in Pde6b-deficient retinas.
  • Demonstration of therapeutic potential for various treatment modalities.

Conclusions:

  • Pde6b mouse models are invaluable for studying arRP pathogenesis.
  • Gene replacement therapy, particularly AAV-mediated, shows significant promise.
  • Multimodal therapeutic strategies may offer the best chance to preserve vision.